You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 10,285,986


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,285,986
Title:Compounds and anti-tumor NQO1 substrates
Abstract: Compositions comprising Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compositions are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.
Inventor(s): Hergenrother; Paul J. (Champaign, IL), Boothman; David A. (Dallas, TX), Bair; Joseph S. (Albany, CA), Palchaudhuri; Rahul (Cambridge, MA), Parkinson; Elizabeth I. (Champaign, IL)
Assignee: The Board of Trustees of the University of Illinois (Urbana, IL) The Board of Regents of the University of Texas System (Austin, TX)
Application Number:15/933,671
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,285,986

Introduction

When evaluating a patent, such as United States Patent 10,285,986, it is crucial to delve into the specifics of the claims, the patent landscape, and the broader context of patent law and procedures. This analysis will help in understanding the patent's validity, its position within the industry, and its potential impact.

Understanding the Patent Claims

What are Patent Claims?

Patent claims define the scope of the invention for which protection is sought. They are the most critical part of a patent application, as they determine what is considered novel, non-obvious, and useful[3].

Analyzing the Claims of US Patent 10,285,986

To analyze the claims of US Patent 10,285,986, one must review the patent document itself. Here are some key steps:

  • Identify the Independent and Dependent Claims: Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.
  • Determine the Scope: Understand what is specifically claimed and how it differentiates from prior art.
  • Evaluate for Novelty, Non-Obviousness, and Utility: Ensure the claims meet the conditions of patentability as defined by the USPTO[3].

The Patent Landscape

What is the Patent Landscape?

The patent landscape refers to the collection of patents and patent applications related to a particular technology or industry. Analyzing this landscape helps in understanding the competitive environment and the positioning of a specific patent.

Tools for Analyzing the Patent Landscape

  • Patent File Wrappers: These contain detailed correspondence between the patent applicant and the examiner, providing insights into the arguments made and the prior art cited. This information is crucial for understanding the patent's legal status and its standing within the landscape[3].
  • Global Dossier: This service by the USPTO allows users to view the file histories of related applications from participating IP offices, providing a comprehensive view of the patent family and related applications[4].

Competitive Intelligence

Analyzing the patent landscape through tools like file wrappers and the Global Dossier can provide valuable competitive intelligence. This includes understanding who is innovating, what technologies are being developed, when key milestones were achieved, and how market trends are evolving[3].

The Examination Process

Overview of the Examination Process

The examination process involves a detailed review by the patent examiner to determine if the claims are novel, non-obvious, and useful. This process can be lengthy and involves multiple office actions and potential revisions to the claims[3].

Trends in Allowance Rates

Historical data shows that the allowance rate for patent applications has decreased over time, particularly in fields like Drugs and Medical Instruments and Computers and Communications. For applications filed between 1996 and 2005, only 55.8% emerged as patents without using continuation procedures[1].

The Role of Prior Art

Prior art plays a critical role in the examination process. The examiner must determine whether the claims overcome the technical features disclosed in prior art. If rejected, the applicant may need to narrow or limit the scope of the claims to satisfy the examiner's arguments[3].

Challenges and Rejections

Overcoming Section 101 Rejections

For patents, especially those involving AI inventions, overcoming section 101 rejections is a significant challenge. The 2024 Guidance Update emphasizes the importance of demonstrating a specific, concrete technological advancement or solution to a technical problem under Step 2A, Prong Two of the subject matter eligibility analysis[5].

Inter Partes Review (IPR) and Post-Grant Review (PGR)

The Leahy-Smith America Invents Act (AIA) introduced IPR and PGR, which allow for administrative challenges to the validity of patents. These procedures can be faster and less expensive than judicial proceedings but have been criticized for creating uncertainty in patent rights[2].

The Impact of Patent Law Changes

The Leahy-Smith America Invents Act (AIA)

The AIA has significantly impacted the patent landscape by introducing new procedures like IPR and PGR. These changes aim to improve patent quality and reduce unwarranted litigation costs but have also raised concerns about the ease of challenging patents and the potential stifling of innovation[2].

The Alice/Mayo Framework

The Supreme Court's Alice/Mayo framework has set a two-step test for patentable subject matter, particularly affecting software and AI patents. This framework requires determining if the patent claims are directed to ineligible subject matter and if they contain an inventive concept that transforms the nature of the ineligible concept[2].

Case Study: US Patent 10,285,986

Detailed Analysis

To conduct a detailed analysis of US Patent 10,285,986, one would need to:

  • Review the patent claims and specifications.
  • Examine the file wrapper to understand the prosecution history, including any office actions and responses.
  • Analyze the prior art cited during the examination process.
  • Evaluate the patent's position within the broader patent landscape using tools like the Global Dossier.

Example Insights

For instance, if US Patent 10,285,986 is in the field of AI, it would be crucial to see how it overcame section 101 rejections by demonstrating a specific technological advancement. The file wrapper would provide insights into the arguments made by the applicant and the examiner, highlighting any challenges faced and how they were addressed.

Key Takeaways

  • Patent Claims are Critical: The claims define the scope of the invention and are essential for determining patentability.
  • Patent Landscape Analysis: Tools like file wrappers and the Global Dossier are vital for understanding the competitive environment.
  • Examination Process: The process is rigorous, and trends show decreasing allowance rates over time.
  • Challenges and Rejections: Overcoming section 101 rejections and navigating IPR/PGR procedures are significant challenges.
  • Impact of Patent Law Changes: The AIA and the Alice/Mayo framework have significantly altered the patent landscape.

FAQs

Q: What is the significance of the file wrapper in patent analysis?

A: The file wrapper contains detailed correspondence between the patent applicant and the examiner, providing insights into the arguments made and the prior art cited, which is crucial for understanding the patent's legal status and its standing within the landscape[3].

Q: How has the Leahy-Smith America Invents Act (AIA) impacted the patent system?

A: The AIA introduced IPR and PGR, aimed at improving patent quality and reducing litigation costs, but it has also raised concerns about the ease of challenging patents and the potential stifling of innovation[2].

Q: What is the Alice/Mayo framework, and how does it affect patentability?

A: The Alice/Mayo framework is a two-step test for patentable subject matter that requires determining if the patent claims are directed to ineligible subject matter and if they contain an inventive concept that transforms the nature of the ineligible concept[2].

Q: Why is it important to analyze the patent landscape?

A: Analyzing the patent landscape provides valuable competitive intelligence, helping to understand who is innovating, what technologies are being developed, and how market trends are evolving[3].

Q: What is the current trend in patent allowance rates?

A: The allowance rate for patent applications has decreased over time, particularly in fields like Drugs and Medical Instruments and Computers and Communications[1].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Congressional Research Service. (2024). The Patent Trial and Appeal Board and Inter Partes Review. CRS Reports.
  3. IP Checkups. (2023). Patent file wrappers as a tool for competitive intelligence.
  4. United States Patent and Trademark Office. (2018). Search for patents - USPTO.
  5. Baker Botts. (2024). The Importance of Prong Two of Step 2A for AI Inventions.

More… ↓

⤷  Subscribe

Details for Patent 10,285,986

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 January 10, 1978 10,285,986 2031-10-14
Genentech, Inc. RITUXAN rituximab Injection 103705 November 26, 1997 10,285,986 2031-10-14
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 September 25, 1998 10,285,986 2031-10-14
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 February 10, 2017 10,285,986 2031-10-14
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 May 07, 2001 10,285,986 2031-10-14
Genzyme Corporation LEMTRADA alemtuzumab Injection 103948 November 14, 2014 10,285,986 2031-10-14
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.